Linda Gibbs is co-founder and Chief Commercial Officer of TGC Health. Linda brings a wealth of expertise to TGC Health with over 30 years of healthcare experience spanning both in global pharmaceutical and life science consultancy organizations.

Before joining TGC Health, Linda spent 21 years in Pfizer Biopharmaceuticals where she held both global and regional commercial leadership roles in the USA, Belgium, and Germany. During her tenure, she successfully led the commercialization of assets in the oncology, vaccines, anti-infectives, endocrinology and pain management therapeutic areas. She launched more than 15 assets across many markets in both Western and Eastern Europe, Latin America, Africa/Middle East, and Asia with a global value of more than $45B.

As the Vice President, Oncology Cluster Lead for the Central and Eastern Europe region, she was specifically responsible for leading a team of more than 200 commercial/sales colleagues in more than 30 countries. Her leadership was focused on commercializing Pfizer’s oncology portfolio that included more than 7 oncology assets. Linda also served as the Lifecycle Planning Lead for Pfizer’s Global Vaccines franchise focused on the COVID vaccine.

Prior to Pfizer, Linda held leadership roles in the USA in healthcare and marketing at Thompson Reuters Healthcare/Physicians World, GeoMed Communications and Dittman Incentive Marketing.

Linda holds a Bachelor of Science Degree and a Master of Business Administration. She is accredited with a Lean Six Sigma Green Belt certification in continuous improvement and has received several marketing and commercialization awards including the Pharmacia/W.E. Upjohn Award for excellence in marketing.